James Holmes was under the influence of prescription drugs and vaccines

The case of the Colorado shooter is one more example of how prescription medications, not guns, are responsible for the lunacy epidemic observed in the United States

By J.D. HEYES | NATURAL NEWS | JANUARY 11, 2013

What was the most deadly element involved in the mass murder of 12 people and the wounding of 58 others at the packed Aurora, Colo., theater premier of the newest “Batman” movie last summer?

Was it the AR-15-type weapon used by James Holmes? The shotgun he had with him? The handgun he used?

No.

As it turns out it was probably a psychotropic medication he was most likely taking, a point raised by Natural News’ Jon Rappoport in August, just weeks after the massacre. [http://www.naturalnews.com].

Holmes had been treated by a psychiatrist

The Denver Post reported Jan. 7 that, according to newly released court papers, police removed a number of prescription medication bottles – four, to be exact – from Holmes’ apartment shortly after clearing it of explosives in the days following the July 20 shootings. They also seized immunization records.

“The disclosures come in a back-and-forth between prosecutors and defense attorneys over whether those items should be subject to doctor-patient confidentiality. The judge ultimately ruled in October that prosecutors could keep the items,” the paper said, adding that the names of the medications had been redacted from court documents.

This shouldn’t come as a huge surprise to anyone who’s been following the correlation between these dangerous psychotropic drugs and mass murder. After all, earlier reports confirmed that Holmes was indeed being seen by a psychiatrist [http://www.nytimes.com], so there’s a better-than-average chance he, too, was on one of these dangerous medications.

The same is true in the most recent shooting tragedy. We know that the Sandy Hook Elementary School shooter, 20-year-old Adam Lanza, had psychological problems. We know, from what Louise Tambascio, a family friend of the shooter and his mother, told the CBS News program, “60 Minutes,” that Lanza “was on medication and everything….I knew he was on medication, but that’s all I know.”

But what was he taking? What was Holmes taking? That we don’t know – yet.

Like us David Kupelian, the managing editor for WorldNetDaily, is asking the right questions.

“It has been more than three weeks since the shooting. We know all about the guns he used, but what ‘medication’ may he have used?” he wrote shortly after the Lanza murders. “So, what is the truth? Where is the journalistic curiosity? Where is the follow-up? Where is the police report, the medical examiner’s report, the interviews with his doctor and others?” writes David Kupelian at WorldNetDaily [http://www.wnd.com]

And yet the national debate, if you can call it that, is focused strictly on the gun control and the Second Amendment, as evidenced by Vice President Joe Biden’s declaration that President Obama plans to use executive power to implement new gun control regulations via the federal agencies that fall under the Executive Branch, and New York Gov. Mario Cuomo’s promise to enact in his state the country’s toughest gun control laws.

As usual, though, the corporate media has failed in its role as watchdog and truth-seeker. It has been left to alternative news outlets like ours and a few others to ask those probing, important questions: What kind of drugs were Holmes and Lanza taking? Who prescribed them? And these questions: What are some of the side effects of those medications? Can such medications cause patients to become violent?

The medications-equals-violence link is well-established

Here’s why it is vitally important for Americans to know what kind of medications Lanza and Holmes were taking – because of earlier, high-profile cases involving guns and psychotropic medications:

— Columbine killer Eric Harris was taking Luvox which, like similar drugs Prozac and Zoloft are widely prescribed antidepressants called selective serotonin reuptake inhibitors, or SSRIs. Luvox manufacturer Solvay Pharmaceuticals admitted that every 1 in 25 patients taking the drug developed mania, a dangerous condition leaving the patient violence-prone.

— Patrick Purdy went on a shooting rampage in a schoolyard in Stockton, Calif., in 1989, an incident that triggered the initial push to ban “assault weapons.” Purdy, who killed five and wounded 30, had been taking the antidepressant Amitriptyline and the anti-psychotic drug Thorzine.

— Fifteen-year-old Kip Kinkel killed his parents in 1998 then went to his school, Thurston High in Springfield, Ore., the next day and fired on his classmates, killing two and wounding 22 more. He was on Prozac and Ritalin.

There are many, many more examples, but you get the point: There exists a distinct link between psychotropic drugs and violence, yet virtually no one in the public policy realm or the media (both of which depend on Big Pharma for donations or advertising dollars) wants to talk about it.

Sources:

http://www.denverpost.com

http://www.infowars.com

http://www.naturalnews.com

http://www.wnd.com

 

Trace from Gardasil vaccine found in brains of two dead girls who were injected

Researchers find that vaccine antigen HPV-16-L1 crossed brain barrier.

By NORMA ERICKSON | SANEVAX | OCTOBER 25, 2012

For the first time in history, a biologically plausible mechanism of action has been discovered linking a vaccine to a serious adverse event. Gardasil has left behind its genetic fingerprint in post-mortem central nervous system samples of two girls who took this vaccine.

Two teenage girls from opposite ends of the world – both dead before their time have two additional things in common. They both took Gardasil to try and prevent cervical cancer and fragments of the HPV-16-L1 antigen used in Gardasil have been found in blood vessels within their brains.

The HPV-16-L1 protein is one of the antigens used in both Gardasil and Cervarix. An antigen is a toxin or other foreign substance that induces an immune response in the body. Theoretically, these antigens are not supposed to cross the blood brain barrier. However, according to a recently concluded case study this may not be the case.

Using a new immunohistochemical (IHC) protocol they developed, Drs. Chris Shaw and Lucija Tomljenovic examined post-mortem samples taken from the cerebellum, hippocampus, choroid plexus and watershed cortex of a 19 year-old girl; as well as post-mortem samples of the cerebellum, hippocampus, choroid plexus, portions of the brainstem (medulla, midbrain, pons), right basal ganglia, right parietal and left frontal lobes of a 14 year-old girl. They tested for the presence of two of the specific antigens used in both Gardasil and Cervarix: HPV-16-L1 and HPV-18-L1.

They discovered the presence of HPV-16-L1 particles within the blood vessels in the brain (cerebral vasculature) with some of these particles adhering to the blood vessel walls. For the average medical consumer, this is the equivalent of a Gardasil fingerprint and it should not be in brain tissues.

Does the presence of HPV-16-L1 particles inside these girls’ cerebral vasculature provide evidence of a “Trojan Horse” mechanism by which these particles adsorbed to aluminum adjuvant gain access to human brain tissue? Remember, both Gardasil and Cervarix contain HPV-16-L1 virus-like particles (VLP’s) of the recombinant major capsid (L1) protein adsorbed onto aluminum adjuvants.

Tomljenovic and Shaw also discovered that the antibodies against HPV-16-L1, which were used to detect the presence of HPV-16-L1 particles, were also binding to the wall of cerebral blood vessels in the brain samples.

Their IHC analysis also showed increased T-cell signaling and marked activation of the classical antibody-dependent complement pathway in cerebral vascular tissues from both cases. This pattern of complement activation, in the absence of an active brain infection, indicates an abnormal triggering of the immune response in which the immune attack is directed towards the blood vessels of the brain, thus triggering an autoimmune cerebral vasculitis.

Cerebral vasculitis is a serious disease which typically results in fatal outcomes when undiagnosed and left untreated. The fact that many of the symptoms reported to the Vaccine Adverse Event Reporting System (VAERS) following HPV vaccination are indicative of cerebral vasculitis, but are unrecognized as such (i.e. intense persistent migraines, syncope, seizures, tremors and tingling, myalgia, locomotor abnormalities, psychotic symptoms and cognitive deficits) is a serious concern in light of Tomljenovic and Shaw’s findings.

Finally, there was clear evidence of brain hemorrhages in both cases which further demonstrated that a serious injury to the cerebral vasculature occurred.

For the average medical consumer, this evidence suggests that the antibodies produced in response to vaccination with the HPV-16-L1 may cause one’s immune system to attack its own blood vessels. HPV vaccines containing HPV-16-L1 antigens could therefore pose an inherent risk for triggering potentially fatal autoimmune vasculopathies.

There is little doubt that HPV vaccines are unsafe for some individuals. Who those individuals are and why they are more susceptible to serious adverse reactions than others remains unknown. More studies must be conducted to answer these questions.

The article by Drs. Chris Shaw and Lucija Tomljenovic entitled Death after qHPV vaccination: causal or coincidental, published in Pharmaceutical Regulatory Affairs today provides evidence of a biologically plausible mechanism of action linking a particular vaccine to serious adverse outcomes, perhaps for the first time in history. Although this study may not conclusively ‘prove’ causality, it seriously demonstrates the need for additional investigation. (Access entire article here.)

When reading this case study, one must understand the findings should be viewed with caution. This is a small sample size and there were no control samples available. However, the marked resemblance between the two cases strongly supports the present conclusions.

It is important to note that activation of the antibody-dependent complement pathway, as shown in Tomljenovic and Shaw’s analysis, typically occurs in neurodegenerative diseases which have an underlying immune trigger. This process is not a feature of a normal young brain.

Given that the autopsy in both cases revealed no major abnormality (anatomically, microbiologically or toxicologically) that might have been regarded as a potential cause of death; it appears plausible that the antigenic component of the HPV vaccine (HPV-16-L1) was indeed responsible for the fatal inflammation of the blood vessels.

Medical consumers need to know:

• Vasculitis has long been recognized as a possible severe adverse reaction to vaccination.
• Molecular mimicry (whereby the vaccine antigen resembles a host antigen) is generally accepted among medical professionals and scientists as a mechanism by which vaccines can trigger autoimmune diseases.
• Tomljenovic & Shaw’s search of the VAERS database revealed numerous reports of post-HPV vaccination–associated vasculitis.
• An analysis of these reports showed that post-HPV vaccination vasculitis-related symptoms most typically manifest within the first three to four months after vaccination, as was also reported in the two cases analyzed by Shaw and Tomljenovic.
• Tomljenovic and Shaw also noted a striking similarity between the vasculitis-related symptoms reported to VAERS and those experienced by the two cases they examined.

Every vaccine carries some risk of adverse effects. Unlike most medications, vaccines are normally administered to healthy individuals. Therefore, it is all the more critical to identify those individuals who are at risk for serious adverse events after vaccines.

We consider ourselves a civilized society. The time has come to stop sacrificing the life and future of anyone for the greater good. The time has come to admit vaccine injuries occur, find out why and cure those already affected. Anything less is neither responsible, nor ethical.

Untested Toxicity Found in Gardasil Vaccine

HPV DNA bound to insoluble aluminum adjuvant.

By NORMA ERICKSON | SANEVAX | OCTOBER 19, 2012

Genetic modification of food has come under severe criticism from the scientific community as new health risks are being discovered. Do genetically modified vaccines carry any less risk? The study below outlines just a few of the unanswered questions about one of the genetically engineered vaccines currently in use, namely Gardasil®.

Dr. Sin Hang Lee of Milford Hospital recently published an article in The Journal of Inorganic Biochemistry entitled, Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine Gardasil®.

According to Dr. Lee’s research (sponsored by SaneVax Inc.), during the manufacture of Gardasil, Merck may have inadvertently created a new chemical compound composed of HPV L1 gene fragments chemically bound to the aluminum nanoparticles of the AAHS adjuvant used in the vaccine.

If this is true, the toxicity of this chemical has not been tested. No one knows what the potential health consequences the injection of this ‘ingredient’ may be.

Consider some key points extracted from the article by Dr. Lee:

A total of 16 samples of Gardasil® received from Australia, Bulgaria, France, India, New Zealand, Poland, Russia, Spain and the United States were found to contain fragments of HPV-18-L1 gene DNA which was readily detected in 15 of 16 samples tested, or HPV-11-L1 gene DNA, or a mixture of both. After submission of the manuscript, HPV-16-L1 gene fragments were also detected among these samples by a special protocol, Dr. Lee noted in his report.

Dr. Lee stated:

“Although the U.S. Food and Drug Administration recently announced that Gardasil® indeed does contain recombinant HPV L1-specific DNA fragments, the physical condition(s) of these HPV DNA fragments in the final vaccine product has not been characterized.”

Dr. Lee presented experimental evidence to assert that the binding mechanism between the HPV L1 gene DNA and the amorphous aluminum hydroxyphosphate sulfate (AAHS) nanoparticles in Gardasil® is of a chemical nature through ligand exchange of phosphate for hydroxyl, independent of the electrostatic forces. When aluminum (Al3+) and DNA interact, the binding site for Al3+ on the DNA chains is the phosphate groups on the DNA backbones.

For the average medical consumer, if the bond between the DNA and aluminum were electrostatic, it would be much like when you rub a balloon against your head until the static electricity builds up to the point where you can stick the balloon to a wall. As you may have noticed, given a short period of time, the balloon loses the static electric charge and falls off the wall. This is much the same as a vaccine in which the bond between the antigen and adjuvant is electrostatic. Once the vaccine is injected, the recipient’s normal pH level reduces the electrostatic attraction making the antigen and adjuvant separate from each other.

On the other hand, if the bond between the DNA and aluminum is chemical, it is more like taking a blob of super-glue and sticking the balloon to the wall. In this instance, no one knows how long the bond will remain intact.

In light of this substantial difference, Dr. Lee concluded:

“The short-term and long-term impact of the residual fragments of HPV L1 gene DNA, or plasmid DNA, if chemically bound to the mineral aluminum of AAHS nanoparticles is largely unknown and warrants further investigation.”

In Sept 2011, the SaneVax Team informed the FDA that HPV DNA fragments had been found firmly attached to the aluminum adjuvant in 100% of Gardasil samples tested by Dr. Sin Hang Lee of Milford Hospital.

The FDA response included the following statement with no references to back it up:

“Recombinant technology has been used for many years to manufacture medicinal products. Gardasil does contain HPV L1-specific DNA fragments. This is expected, since DNA encoding the HPV L1 gene is used in the vaccine manufacturing process to produce the virus-like particles. The presence of these expected DNA fragments, which are inevitable in vaccine production, is not a risk to vaccine recipients, is not harmful, and this DNA is not a contaminant.”

As you can clearly see, there is no mention whatsoever is made about these fragments possibly being firmly attached to the aluminum adjuvant. The SaneVax Team as well as many eminent scientists and medical professionals around the world believe this ‘tiny’ detail should not be ignored.

If this ‘ingredient’ is indeed an ‘inevitable’ component of recombinant technology, medical consumers have a right to know when, for how long and under what circumstances it was tested for safety.

After an entire year of multiple communication attempts receiving no scientific documentation from the FDA that this ‘ingredient’ did not pose a health threat, the SaneVax Team sent another letter to the FDA Commissioner with one simple request.

This letter asked for copies of documents from the FDA showing:

1)    The date when the FDA and the manufacturer first knew small quantities of residual recombinant HPV L1-specific DNA fragments remain in the vaccine.

2)    The physical condition of the HPV- L1-specific DNA fragments in the Gardasil® vaccine.

To date, the FDA has made no effort to respond to this request. Do they have any documentation? If so, why do they not provide this critical information to medical consumers?

Surely, considering the fact that these fragments are an ‘inevitable’ component of recombinant technology, they have requested safety studies to determine any potential health impact. After all, they are responsible for the health and safety of medical consumers – aren’t they?

One more critical point:

Why did Merck not detect the residues of HPV-18-L1 gene DNA during the production of Gardasil®?

Dr. Lee offered the following explanation:

“…all HPV-18 isolates can be classified into 3 subtypes based on alignments of the DNA sequences of the variants, (i.e. the European, the Asian-American and the African subtypes). In Europe, it has been reported that all of the HPV-18 isolates from patients are found to be of the European or Asian-American variants. In the U.S., 91% of the HPV-18 isolates from white women are reported to be of the European and Asian-American variants, and 64% of the HPV isolates from African American women belong to the African variant.

Since the prevalence of the African variants of HPV-18 among European patients is negligible, the Dutch researchers who originally developed the HPV INNO-LIPA kit naturally selected an HPV-18 probe targeting a homologous sequence shared by all European and Asian-American HPV-18 variants for the testing.

However, the HPV-18 L1 protein-coding gene chosen by the manufacturer for Gardasil® closely related to an African subtype. Failure to detect a target sequence of an African variant HPV-18 DNA in the vaccine Gardasil® with a hybridization probe specifically designed for the European and Asian-American DNA variants may simply reflect the diversity of the L1 protein amino acid sequences within the genotype of HPV-18.”

For medical consumers, this brings additional questions. Has Gardasil® been tested for efficacy against all three HPV-18 variants?

Are families in the United States and Europe putting their children at risk of unknown health consequences resulting from the injection of a new chemical with untested toxicity in order to obtain ‘protection’ against only one type of oncogenic HPV?

The time has come for medical consumers to hold their national health ‘authorities’ accountable. These questions must be answered before any more children become ‘one less.’

(Note: Dr. Lee’s study was commissioned and sponsored by SaneVax Inc. for a future payment not to exceed one U.S. dollar.)

Vasculitis and Vaccines: A Parent’s Primer

By NORMA ERICKSON | SANEVAX | OCTOBER 15, 2012

What is vasculitis?

Vasculitis is considered a rare group of disorders caused by inflammation of blood vessels. It is a condition which is easy to miss, or misdiagnose, because inflammation of blood vessels is capable of causing a wide range of symptoms which can be vague, generalized and/or non-specific depending upon whether veins or arteries are affected, where these blood vessels are located, how wide-spread the inflammation is, and the degree to which the blood flow is restricted in the affected area.[1] [2]

How vasculitis presents itself depends upon which tissues, organs or systems are affected, and to which degree they are affected by the impaired blood flow resulting from inflammation.

For example:

• CNS (central nervous system) vasculitis[3] may cause headaches, confusion, changes in personality, seizures, vision problems, tingling, loss of feeling, weakness, paralysis or other neurological problems including permanent disability.
• Churg-Strauss vasculitis[4] can have symptoms similar to asthma because of lung involvement. Can include shortness of breath, wheezing, chest pain, and coughing up blood.
• Henoch-Schönlein purpura[5] can present as small raised purple areas under the skin (purpura) due to hemorrhage, abdominal pain, nausea, vomiting, joint pain, or blood in the urine (hematuria) because of its systemic involvement.
• Temporal arteritis[6] can cause headache and tender thick blood vessels on the side of the forehead. Can also cause fatigue, loss of appetite (then weight), fever, heavy sweating, fever, joint and muscle pain.
• Cutaneous vasculitis[7] may cause petechiae (small red dots), purpura, urticaria (hives), bruising, or ulcers of the skin.

The symptoms listed above are by no means an exhaustive list, but it does give you some idea of the various possible manifestations and how easily vasculitis can be mistaken for a multitude of other disorders.

What does vasculitis have to do with vaccines?

If you do a simple Google search for ‘vasculitis and vaccines,’ you will see over 500,000 results. Consider the following quotes from a few of the scientific articles referenced:

• “A      14-year-old boy who had no relevant previous history and who was not      taking any drugs presented with a livedo reticularis (mottling of the      skin), fever, loss of weight, testicular pain, and paresthesias two months      after receiving the third dose of a hepatitis B vaccination. Inflammatory      parameters (ESR and CRP) were high. The patient met the ACR diagnostic      criteria for polyarteritis nodosa.”[8]      [9]
• “Here      we describe 4 cases of new onset or relapsing antineutrophil cytoplasmic      antibodies associated vasculitis occurring in timely association with      influenza vaccination. In the literature different subtypes of vasculitis      have been repeatedly reported after influenza vaccination.”[10]
• “…anecdotal      cases continue to be reported of autoimmune phenomena following influenza      vaccination, including SLE, RA, pericarditis and various forms of      vasculitis.”[11]
• “Giant      cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory      rheumatic diseases common in people over the age of 50 years. Herein, we      report 10 cases of previously healthy subjects who developed GCA/PMR      within 3 months of influenza vaccination (Inf-V). A Medline search      uncovered additional 11 isolated cases of GCA/PMR occurring after Inf-V.”[12]
• “We      describe here a case of Henoch-Schönlein purpura (HSP) that occurred 10      days after administration of the meningococcal      polysaccharide vaccine and came to the attention of      a Vaccine Safety Datalink (VSD) investigator (but did not occur      in the VSD cohort). Periodic case reports have      linked vaccines to HSP.”[13]
• “The      aim of this study was to characterize the adverse events of attenuated      measles vaccine in mainland China. …28 cases of Henoch-Schonlein      purpura (HSP) were reported.”[14]
• “We      report the original case of cutaneous periarteritis nodosa that occurred      one month following vaccination against hepatitis B.”[15]
• “We      report a case of biopsy proven vasculitis, presenting as mononeuritis      multiplex, following influenza vaccination. The clinical picture evolved      rapidly into a syndrome indistinguishable from axonal Guillain-Barré      syndrome. This suggests a differential diagnosis for post-vaccination      neuropathy, with implications for management. We believe this is the first      report in which there was an associated peripheral neuropathy at      presentation. It raises issues about the aetiology and pathogenesis of      vaccination associated neuropathy.”[16]

It is important to note that none of these studies have identified a direct causal relationship between the vaccine administered and the outcomes observed. Each one, however, exhibits a strong temporal association between the vaccine and the outcome. This means that the observed adverse events occurred within a time-frame where it is reasonable to consider the event was potentially caused by the vaccine.

In general, disorders caused by vasculitis are serious and need to be evaluated promptly. The problem is they may be difficult (even for doctors) to recognize because of the significant overlap of signs and symptoms with other more common conditions.

According to Dr. Yehuda Shoenfeld:[17] [18]

“Vaccination can have adverse autoimmune effects and may even trigger full-blown autoimmune disorders. At the moment, it is not possible to identify who is most prone to develop these side effects or disorders after immunization. Further research is needed to identify these individuals.”

The SaneVax Team could not agree more. More research does need to be done in the area of vaccine injuries – who is susceptible and why?

What do parents do while waiting for the research? 

Every time someone in your family receives a vaccination, have the person administering the vaccine record the name of the vaccine, the lot number and the expiration date. Keep a copy for your records.

Keep a journal of every new medical condition experienced after vaccination. Do not worry about whether or not you think it may be related to the vaccination – that is up to the experts to try and determine. The point is your written record may prove invaluable should you or your child actually be the victim of an adverse reaction to a vaccine.

Talk to your doctor if you suspect vasculitis or any other adverse reaction. Keep in mind that since adverse reactions to vaccines are considered rare, most physicians are not trained to recognize them. You may have to back up any concerns with your own research. Should you need to do this, stick to published scientific articles and studies. Medical professionals will not consider other sources credible.

If you and your doctor disagree, consider obtaining a second opinion. You have every right to do so.

Learn how vasculitis is typically diagnosed:

In general, disorders caused by vasculitis are serious and need to be evaluated promptly. The problem is they may be difficult for even doctors to recognize because of the significant overlap of signs and symptoms with other more commonly encountered disorders.

The diagnosis of any type of vasculitis involves tests to demonstrate the presence of a strong inflammatory process. Tests which reveal inflammation throughout the body include erythrocyte sedimentation rate, blood tests to reveal anemia/increased white blood cells, or tests to demonstrate the presence of immune complexes and/or antibodies circulating in the blood. An x-ray procedure called angiography can sometimes be used or biopsies taken from affected organs to demonstrate inflammation.[19]

---

[1] http://medical-dictionary.thefreedictionary.com/vasculitis

[2] http://www.emedicinehealth.com/vasculitis/article_em.htm

[3] http://my.clevelandclinic.org/disorders/vasculitis/hic_central_nervous_system_vasculitis.aspx

[4] http://www.hopkinsvasculitis.org/types-vasculitis/churgstrauss-syndrome-css/

[5] http://www.mayoclinic.com/health/henoch-schonlein-purpura/DS00838

[6] http://www.mayoclinic.com/health/giant-cell-arteritis/DS00440

[7] http://www.merckmanuals.com/professional/musculoskeletal_and_connective_tissue_disorders/vasculitis/cutaneous_vasculitis.html

[8] http://www.ncbi.nlm.nih.gov/pubmed/19046721

[9] http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002410/

[10] http://www.ncbi.nlm.nih.gov/pubmed/19734734

[11] http://rheumatology.oxfordjournals.org/content/42/7/907.full

[12] http://www.ncbi.nlm.nih.gov/pubmed/22235046

[13] http://www.ncbi.nlm.nih.gov/pubmed/20624811

[14] http://www.ncbi.nlm.nih.gov/pubmed/19909830

[15] http://www.ncbi.nlm.nih.gov/pubmed/12671586

[16] http://jnnp.bmj.com/content/75/10/1507.full

[17] http://www2.tau.ac.il/Person/medicine/researcher_data.asp?type_data=education&id=abkgceihd&el_name=Shoenfeld&ef_name=Yehuda&dep_num=0100&sub_dep_num=0124

[18] http://www.ncbi.nlm.nih.gov/pubmed/19046721

[19] http://medical-dictionary.thefreedictionary.com/vasculitis

13,000 People Exposed Vaccines now Contaminated with Rare Fungal Meningitis

By LISA GARBER | NATURAL SOCIETY | OCTOBER 9, 2012

As of Monday, contaminated steroids have sickened 105 people with a noncontagious but deadly form of fungal meningitis, while 13,000 people may have been exposed to the contamination. Eight have died. Health officials attribute the outbreak to spinal steroid injections for back pain. The Food and Drug Administration (FDA) found fungus in sealed vials of the steroid in question, produced by the Massachusetts-based pharmacy, New England Compounding Center (NECC). The NECC voluntarily recalled all of its products on Saturday and surrendered its license to operate until completion of the FDA’s investigation.

You can find a list of the 76 medical facilities that obtained the steroid at the Centers for Disease Control and Prevention website.

 What is Fungal Meningitis?

Meningitis inflames the membranes protecting the brain and spinal cord. Usually brought on by a viral or bacterial infection, fungal infection is rare and not contagious but no less deadly. Symptoms include headache; fever; nausea; stiffness of the neck; and (in the case of fungal infection) confusion, dizziness, and aversion to bright light. Dr. William Schaffner of Vanderbilt University Medical Center says that because blood vessels clot or bleed in response to fungal infections, symptoms are rarely mild and can be as severe as small strokes.

Because patients treated earlier have greater chances of survival, health officials encourage people with symptoms to seek aid.

Other Dangers of Pharmaceuticals

About 1 in 10 drugs administered in the U.S. are manufactured in compound facilities, which do not answer to FDA mandates and instead go through state health pharmacy boards before sale.

To be fair, the FDA is complicit in a number of other conditions resultant of vaccines and harmful pharmaceuticals.  In example, after being administered steroids for an asthma attack, Shanyna Isom developed a skin condition wherein she grows fingernails instead of hair. Her condition is the only one recorded in the world and has cost her family over a quarter of a million dollars in medical bills.

Additionally, a report from the Journal of Trace Elements in Medicine and Biology found states that aluminum hydroxide in vaccines may cause a deadly aluminum overdose for children and adults. Vaccines have also been linked to autism, Guillain-Barre syndrome, paralysis, and death in addition to less severe chronic conditions like allergies and autoimmune diseases.